HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 553-564 of 4,505
Behavioral study icon
Not Yet RecruitingACTRN12619000853145

The Actionable Intime Insights (AI2) Study: Implementing a digital model for timely and needs-based interventions for individuals on anti-psychotic medication in mental health services by applying algorithms to health care data

Official study title

Using algorithms to dynamically initiate needs-based interventions for individuals on anti-psychotic medication: Implementation of The Actionable Intime Insights (AI2) Application in community mental health services

This study isn't recruiting yet.

In Australia
Schizophrenia, BipolarityInterventional studyAges 18+
Countries
Australia
Sponsor
Flinders University
Drug study icon
Not Yet RecruitingACTRN12610000911099

The metabolic effect of antipsychotic medication

Official study title

The effect of antipyschotic medication in healthy volunteers on glucose metabolism and gut hormones

This study isn't recruiting yet.

In New Zealand
SchizophreniaInterventional studyAges 18–40
Countries
New Zealand
Sponsor
University of Auckland
Other study type icon
CompletedNCT00001486

Genetic Study of Schizophrenia

Official study title

A Neurobiological Investigation of Patients With Schizophrenia Spectrum Disorders and Their Siblings

This study has finished and is no longer accepting participants.

In Bethesda
SchizophreniaObservational studyAges 18–55
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)
Drug study icon
CompletedNCT03510741

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in people with Early Schizophrenia Spectrum Disorder.

Official study title

A Multicentre 12-week Randomised Double-blind Placebo Controlled Feasibility Trial of Sodium Benzoate and/or N-acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

This study has finished and is no longer accepting participants.

Multiple locations, including Quetta
SchizophreniaMedication studyAges 18–35
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Other study type icon
CompletedNCT02664129

Video as a Tool to Improve Insight in Schizophrenia

Official study title

Video Self-observation as a Therapeutic Tool for Improving the Insight of Patients With Schizophrenia Disorders

This study has finished and is no longer accepting participants.

Multiple locations, including Montpellier
SchizophreniaInterventional studyAges 18–65
Countries
France
Sponsor
University Hospital, Montpellier

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.